Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus

Journal of Clinical Gastroenterology

Volumn 39, Issue 8, 2005, Pages 653-664

  Wolfsen, Herbert C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cholangiocarcinoma; Endoscopic ablation; Helicobacter pylori; Porfimer sodium

Indexed keywords

AMINOLEVULINIC ACID; CARCINOEMBRYONIC ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMATOPORPHYRIN DERIVATIVE; METHYLENE BLUE; MONOCLONAL ANTIBODY; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM; PROTOPORPHYRIN; TALAPORFIN; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TOLONIUM CHLORIDE;

ABDOMINAL PAIN; ADENOMATOUS POLYP; ANIMAL CELL; BARRETT ESOPHAGUS; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS VARICES; EUROPE; FEVER; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; INTESTINE HEMATOMA; INTESTINE NECROSIS; NONHUMAN; PAIN; PANCREAS; PARALYTIC ILEUS; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PIGMENT DISORDER; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VATER PAPILLA TUMOR;

CHOLANGIOCARCINOMA; GASTROINTESTINAL NEOPLASMS; HUMANS; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS;

EID: 23844435240     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000173930.60115.62     Document Type: Review

References (161)

1. Dougherty TJ, Corner CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
2. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res. 1998;150(suppl):146-156.
3. Korbelik M, Parkins CS, Shibuya H, et al. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br J Cancer. 2000;82:1835-1843.
4. Hsi RA, Rosenthal DI, Glatstein E. Photodynamic therapy in the treatment of cancer: current state of the art. Drugs. 1999;57:725-734.
5. Luo Y, Kessel D. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol. 1997;66:479-483.
6. He J, Oleinick NL. Cell death mechanisms vary with photodynamic therapy dose and photosensitizer. 5th International Photodynamic Association Biennial Meeting, Amelia Island, FL, 1995.
7. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85:443-456.
8. Levy JG, Obochi M. New applications in photodynamic therapy: introduction. Photochem Photobiol. 1996;64:737-739.
9. Trauner KB, Hasan T. Photodynamic treatment of rheumatoid and inflammatory arthritis. Photochem Photobiol. 1996;64:740-750.
10. Panjehpour M, Overholt BF, Haydek JM. Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract. Gastrointest Endosc Clin North Am. 2000;10:513-532.
11. Wolfsen HC. Photodynamic therapy in gastroenterology: current status in year 2000. Endoscopy. 2000;32:715-719.
12. Carruth JA. Clinical applications of photodynamic therapy. Int J Clin Pract. 1998;52:39-42.
13. Prosst RL, Wolfsen HC, Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy. 2003;35:1059-1068.
14. Wolfsen HC, Hemminger LL, Wallace MB, et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther. 2004;20:1-7.
15. Wolfsen HC. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol. 2005;39:189-202.
16. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg. 1996; 224:628-638.
17. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228: 385-394.
18. Rumalla A, Baron TH. Evaluation and endoscopic palliation of cholangiocarcinoma: management of cholangiocarcinoma. Dig Dis. 1999; 17:194-200.
19. Ede RJ, Williams SJ, Hatfield AR, et al. Endoscopic management of inoperable cholangiocarcinoma using iridium-192. Br J Surg. 1989;76: 867-869.
20. Levitt MD, Laurence BH, Cameron F, et al. Transpapillary iridium-192 wire in the treatment of malignant bile duct obstruction. Gut. 1988;29: 149-152.
21. Johnson DW, Safai C, Goffinet DR. Malignant obstructive jaundice: treatment with external-beam and intracavitary radiotherapy. Int J Radiat Oncol Biol Phys. 1985;11:411-416.
22. Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg. 1995;82:1522-1525.
23. Bowling TE, Galbraith SM, Hatfield AR, et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut. 1996;39:852-855.
24. Terrazzi V, Minoli G. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastrointest Endosc. 1999;50:727-728.
25. McCaughan JS Jr, Mertens BF, Cho C, et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts: a case report. Arch Surg. 1991;126:111-113.
26. Wong Kee Song LM, Wang KK, Zinsmeister AR. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer. 1998;82:421-427.
27. Pahemik SA, Dellian M, Berr F, et al. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B. 1998; 47:58-62.
28. Ortner MA, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology. 1998;114:536-542.
29. Ortner MA, Liebetruth J, Giesse A, et al. Photodynamic therapy of nonresectable cholangiocellular carcinoma [Abstract]. Gastroenterology. 1998;114:A535.
30. Berr F, Wiedmann M, Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology. 2000;31:291-298.
31. Zoepf T, Jakobs R, Arnold J, et al. Photodynamic therapy (PDT) for palliation of nonresectable bile duct cancer: first results with a new diode laser system [Abstract]. Gastroenterology. 1999;116:A536.
32. Zoepf T, Jakobs R, Arnold JC, et al. Photodynamic therapy for palliation of nonresectable bile duct cancer: preliminary results with a new diode laser system. Am J Gastroenterol. 2001;96:2093-2097.
33. Burdick JS, Magee D, Miller G, et al. Biliary photodynamic therapy alternative delivery technique. Endoscopy. 2000;32(suppl):63.
34. Berr F, Tannapfel A, Pahemik S, et al. Selective local control of bile duct cancer by photodynamic therapy [Abstract]. Hepatology. 1997; 26:165.
35. Berr F, Tannapfel A, Lamesch P, et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol. 2000;32:352-357.
36. Rumalla A, Baron TH, Wang KK, et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc. 2001;53:500-504.
37. Dumoulin FL, Gerhardt T, Fuchs S, et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2003;57:860-867.
38. Zoepf T, Jakobs R, Rosenbaum A, et al. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer [Abstract]. Gastroenterology. 2000;118:A528.
39. Zoepf T, Jakobs R, Rosenbaum A, et al. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. Gastrointest Endosc. 2001;54:763-766.
40. Ortner M. Photodynamic therapy in the biliary tract. Curr Gastroenterol Rep. 2001;31154-159.
41. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125:1355-1363.
42. Wiedmann M, Caca K, Berr F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer. 2003;97:2783-2790.
43. Nanashima A, Yamaguchi H, Shibasaki S, et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol. 2004;39:1095-1101.
44. Harewood GC, Baron TH, Rumalla A, et al. [Abstract]. Prospective assessment of patient outcome following photodynamic therapy for advanced cholangiocarcinoma. Gastrointest Endosc. 2004;59:AB190.
45. Harewood GC, Baron TH, Rumalla A, et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol. 2005;20:415-420.
46. Ortner MA. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest Endosc Clin North Am. 2000;10:481-486.
47. Khan SA, Sharif AW, Taylor-Robinson SD. Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma. Cancer Treat Rev. 2004;30:315-318.
48. Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology. 2005;41:5-15.
49. Gossner L, Ell C. Photodynamic therapy of gastric cancer. Gastrointest Endosc Clin North Am. 2000;10:461-480.
50. Yanai H, Tada M, Karita M, et al. Diagnostic utility of 20-megahertz linear endoscopic ultrasonography in early gastric cancer. Gastrointest Endosc. 1996;44:29-33.
51. Winkler M, Jentschura D, Winter J, et al. Results of surgical therapy of early stomach cancer. Zentralbl Chir. 1995;120:795-799.
52. Takeshita K, Tani M, Inoue H, et al. Endoscopic treatment of early oesophageal or gastric cancer. Gut. 1997;40:123-127.
53. Inoue H, Endo M, Takeshita K, et al. Endoscopie resection of early-stage esophageal cancer. Surg Endosc. 1991;5:59-62.
54. Takekoshi T, Baba Y, Ota H, et al. Endoscopic resection of early gastric carcinoma: results of a retrospective analysis of 308 cases. Endoscopy. 1994;26:352-358.
55. Kato T, Tanaka H, Honda T, et al. Extensive abnormal radiographic findings in the maxilla and mandible. Fukuoka Shika Daigaku Gakkai Zasshi. 1986;13:67-73.
56. Ell C, Gossner L, May A, et al. Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut. 1998;43:345-349.
57. Jin M, Yang B, Zhang W, et al. Photodynamic therapy for upper gastrointestinal tumours over the past 10 years. Semin Surg Oncol. 1994; 10:111-113.
58. Hayata Y, Kato H, Okitsu H, et al. Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract. Semin Surg Oncol. 1985;1:1-11.
59. Patrice T, Foultier MT, Yactayo S, et al. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Dig Dis Sci. 1990;35: 545-552.
60. Gossner L, Sroka R, Hahn EG, et al. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc. 1995;41:55-58.
61. Tajiri H, Daikuzono N, Joffe SN, et al. Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc. 1987;33:88-90.
62. Hayata Y. Overview of clinical photodynamic therapy. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic Therapy and Biomedical Lasers: Proceedings of the International Conference on Photodynamic Therapy and Medical Laser Applications, Milan, 24-27 June 1992, International Congress series, no. 1011. Amsterdam: Excerpta Medica, 1992:1-5.
63. Kato H. Photodynamic therapy in the early treatment of cancer [Abstract]. Can To Kagaku Ryoho. 1990;17:1833-1838.
64. Mimura S. Photodynamic therapy for early gastric cancer using eximer dye laser. In: Spinelli P, Dal Fante M, Marchesini R. eds. Photodynamic Therapy and Biomedical Lasers: Proceedings of the International Conference on Photodynamic Therapy and Medical Laser Applications, Milan, 24-27 June 1992, International Congress series, no. 1011. Amsterdam: Excerpta Medica, 1992:1-5.
65. Mimura S. Photodynamic therapy for early gastric cancer, 5th International Photodynamic Association Biennial Meeting, Amelia Island, Florida, 1994.
66. Nakamura T, Fukui H, Ishii Y, et al. Shape-memory alloy loop snare for endoscopic photodynamic therapy of early gastric cancer. Endoscopy. 2000;32:609-613.
67. Tada M. Endoscopic mucosal resection of the stomach: initial description. Gastrointest Endosc Clin North Am. 2001;11:499-510.
68. Suzuki H. Endoscopic mucosal resection using ligating device for early gastric cancer. Gastrointest Endosc Clin North Am. 2001;11:511-518.
69. Rajan E, Gostout CJ, Feitoza AB, et al. Widespread EMR: a new technique for removal of large areas of mucosa. Gastrointest Endosc. 2004;60:623-627.
70. Marshall BJ, Royce H, Annear DI, et al. Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbiol Lett. 1984;25:83-84.
71. Wolfsen HC, Talley NJ. The diagnosis and treatment of duodenal and gastric ulcer. In: Goodwin CS, Wormsley B, eds. Helicobacter pylori: Biology and Clinical Practice. Boca Raton, FL: CRC Press, 1993;365-395.
72. McNulty CAM. Treatment of Campylobacter pylori infection: Microbiological viewpoint. In: Blasser MJ, ed. Campylobacter pylori in Gastritis and Peptic Ulcer Disease. New York: Igaku-Shoin, 1989.
73. Bedwell J, Holton J, Vaira D, et al. In vitro killing of Helicobacter pylori with photodynamic therapy. Lancet. 1990;335:1287.
74. Wolfsen HC, Wang KK, Ahlquist D, et al. Light dosimetry in photodynamic therapy for Helicobacter pylori. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic Therapy and Biomedical Lasers. Amsterdam: Elsevier Science Publishers, 1992:281-285.
75. Bown SG, Millson CE. Photodynamic therapy in gastroenterology. Gut. 1997;41:5-7.
76. Millson CE, Wilson M, MacRobert AJ, et al. Ex-vivo treatment of gastric Helicobacter infection by photodynamic therapy. J Photochem Photobiol B. 1996;32:59-65.
77. Millson CE, Wilson M, Macrobert AJ, et al. The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitiser. J Med Microbiol. 1996;44:245-252.
78. European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Gut. 1997;41:8-13.
79. Wang KK, Wolfsen HC. Tolerance of normal swine gastric epithelium to photodynamic therapy using topically applied hematoporphyrin derivative [Abstract]. Lasers Surg Med. 1993;15:A364.
80. Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci. 2004;3:436-450.
81. Rovaldi CR, Pievsky A, Sole NA, et al. Photoactive porphyrin derivative with broad-spectrum activity against oral pathogens In vitro. Antimicrob Agents Chemother. 2000;44:3364-3367.
82. Ganz RA, Hamblin MR, Tolkoff J, et al. Helicobacter pylori in patients is killed by visible light [Abstract]. Am J Gastroenterol. 2003; 98(suppl 9):47.
83. Yamamoto Y, Shibuya H, Okunaka T, et al. Fibrin plugging as a cause of microcirculatory occlusion during photodynamic therapy. Lasers Med Sci. 1999;14:129-135.
84. Chang CJ, Sun CH, Liaw LH, et al. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells. Lasers Surg Med. 1999;24:178-186.
85. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B. 1997;39: 1-18.
86. McCaughan JS Jr, Hawley PC, LaRosa JC, et al. Photodynamic therapy to control life-threatening hemorrhage from hereditary hemorrhagic telangiectasia. Lasers Surg Med. 1996;19:492-494.
87. Ido K, Yamamoto H, Kawamoto C, et al. Esophageal varices obliterated by photodynamic therapy for coexisting early esophageal carcinoma. Gastrointest Endosc. 1997;45:420-423.
88. Wong Kee Song LM, Wang KK, Nourbakhsh A. Photodynamic therapy for management of refractory hemorrhagic radiation proctitis [Abstract]. Gastrointest Endosc. 1998;47:AB106.
89. McCaughan JS Jr. Miscellaneous treatments. In: JS McCaughan Jr, ed. Photodynamic Therapy for Malignancies: Clinical Manual. Austin, TX: Landes, 1992:135-144.
90. Herrera-Ornelas L, Petrelli NJ, Mittelman A, et al. Photodynamic therapy in patients with colorectal cancer. Cancer. 1986;57:677-684.
91. Abulafi AM, Dejode ML, Allardice JT, et al. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer. Br J Surg. 1997;84:368-371.
92. Ansell JK, Abulafi AM, Allardice JT, et al. Adjuvant intraoperative photodynamic therapy for colorectal cancer. Br J Surg. 1996;83:694.
93. Wolfsen HC, Hemminger LL. Photodynamic therapy for dysplastic Barren's esophagus and mucosal adenocarcinoma [Abstract]. Gastrointest Endosc. 2004;59:AB251.
94. Mimura S, Ichii M, Imanishi K, et al. Indications for and limitations of HpD photodynamic therapy for esophageal cancer and gastric cancer. Gan To Kagaku Ryoho. 1988;15:1440-1444.
95. Scheider DM, Siemens M, Cirocco M, et al. Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents. Endoscopy. 1997;29:271-274.
96. Conio M, Gostout CJ. Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents. Gastrointest Endosc. 1998; 48:225.
97. Kashiwagi H, Spigelman AD. Gastroduodenal lesions in familial adenomatous polyposis. Surg Today. 2000;30:675-682.
98. Bulow S, Alm T, Fausa O, et al. Duodenal adenomatosis in familial adenomatous polyposis: DAF Project Group. Int J Colorectal Dis. 1995; 10:43-46.
99. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102:1980-1982.
100. Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs: its rational treatment. Ann Surg. 1993;217:101-108.
101. Mlkvy P, Messmann H, Debinski H, et al. Photodynamic therapy for polyps in familial adenomatous polyposis: a pilot study. Eur J Cancer. 1995;31A:1160-1165.
102. Abulafi AM, Allardice JT, Williams NS, et al. Photodynamic therapy for malignant tumours of the ampulla of Vater. Gut. 1995;36:853-856.
103. Saurin JC, Ponchon T, Descos F, et al. Photodynamic Therapy (PDT) targeted to the proximal duodenum in familial adenomatous polyposis (FAP) [Abstract]. Gastrointest Endosc. 1998;47:AB38.
104. MergenerK, Branch M. Photodynamic therapy for malignant tumours of the ampulla of Vater. Gastrointest Endosc. 1997;45:220-221.
105. Liu CD, Kwan D, Saxton RE, et al. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res. 2000; 93:137-143.
106. Hajri A, Coffy S, Vallat F, et al. Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo. Br J Surg. 1999; 86:899-906.
107. Keller P, Sowinska M, Tassetti V, et al. Photodynamic imaging of a rat pancreatic cancer with pheophorbide a. Photochem Photobiol. 1996;63: 860-867.
108. Evrard S, Keller P, Hajri A, et al. Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg. 1994;81:1185-1189.
109. Mlkvy P, Messmann H, Pauer M, et al. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer. 1996;73: 1473-1479.
110. Mlkvy P, Messman H, MacRobert AJ, et al. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC). Br J Cancer. 1997;76:713-718.
111. Schroder T, Chen IW, Sperling M, et al. Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma. J Surg Oncol. 1988;38:4-9.
112. Ayaru L, Bown SG, Pereira SP. Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer. 2005;35:1-14.
113. Rogowska A, Whitelaw DE, Lees WR, et al. Photodynamic therapy for palliation of unresectable pancreatic cancer [Abstract]. Gastroenterology. 1999;116:A1159.
114. Bown SG, Lovat LB. The biology of photodynamic therapy in the gastrointestinal tract. Gastrointest Endosc Clin North Am. 2000;10:533-550.
115. Bown SG, Rogowska AZ, Whitelaw DE, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50:549-557.
116. Chan HH, Nishioka NS, Mino M, et al. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc. 2004;59:95-99.
117. Krasner N. Laser therapy in the management of benign and malignant tumours in the colon and rectum. Int J Colorectal Dis. 1989;4:2-5.
118. Barr H, Krasner N, Boulos PB, et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg. 1990;77:93-96.
119. Patrice T, Foultier MT, Yactayo S, et al. Endoscopic photodynamic therapy with haematoporphyrin derivative in gastroenterology. J Photochem Photobiol B. 1990;6:157-165.
120. Karanov S, Kostadinov D, Shopova M, et al. Photodynamic therapy in lung and gastrointestinal cancers. J Photochem Photobiol B. 1990;6:175-181.
121. Eckhauser ML. Laser therapy of coloiectal carcinoma. Surg Clin North Am. 1992;72:597-607.
122. Loh CS, MacRobert AJ, Bedwell J, et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer. 1993;68:41-51.
123. Loh CS, Bliss P, Bown SG, et al. Photodynamic therapy for villous adenomas of the colon and rectum. Endoscopy. 1994;26:243-246.
124. Spinelli P, Mancini A, Dal Fante M. Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy. Semin Surg Oncol. 1995;11:307-318.
125. Fromm D, Kessel D, Webber J. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch Surg. 1996; 131:667-669.
126. Kashtan H, Papa MZ, Wilson BC, et al. Use of photodynamic therapy in the palliation of massive advanced rectal cancer: Phase I/II study. Dis Colon Rectum. 1991;34:600-604; discussion 604-605.
127. Spinelli P, Dal Fante M, Mancini A. Current role of laser and photodynamic therapy in gastrointestinal tumors and analysis of a 10-year experience. Semin Surg Oncol. 1992;8:204-213.
128. Mlkvy P, Messmann H, Regula J, et al. Photodynamic therapy for gastrointestinal tumors using three photosensitizers: ALA induced PPIX, Photofrin and MTHPC. A pilot study. Neoplasma. 1998;45:157-161.
129. Del Governatore M, Hamblin MR, Piccinini EE, et al. Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer. 2000;82:56-64.
130. Carcenac M, Larroque C, Langlois R, et al. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. Photochem Photobiol. 1999;70: 930-936.
131. Golab J, Wilczynski G, Zagozdzon R, et al. Potentiation of the antitumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer. 2000;82:1485-1491.
132. Melnikova V, Bezdetnaya L, Belitchenko I, et al. Meta- tetra(hydroxyphenyl)chlorin-sensitized photodynamic damage of cultured tumor and normal cells in the presence of high concentrations of alpha-tocopherol. Cancer Lett. 1999;139:89-95.
133. Matroule JY, Hellin AC, Morliere P, et al. Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization. Photochem Photobiol. 1999;70:540-548.
134. Fabiano AS, Allouche D, Sanejouand YH, et al. Synthesis of a new cationic pyropheophorbide derivative and studies of its aggregation process in aqueous solution. Photochem Photobiol. 1997;66:336-345.
135. Oseroff AR, Ohuoha D, Ara G, et al. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc Natl Acad Sci USA. 1986;83:9729-9733.
136. Orth K, Beck G, Genze F, et al. Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J Photochem Photobiol B. 2000;57:186-192.
137. Gederaas OA, Rasch MH, Berg K, et al. Photodynamically induced effects in colon carcinoma cells (WiDr) by endogenous photosensitizers generated by incubation with 5-aminolaevulinic acid. J Photochem Photobiol B. 1999;49:162-170.
138. Baumler W, Abels C, Karrer S, et al. Photo-oxidative killing of human colonie cancer cells using indocyanine green and infrared light. Br J Cancer. 1999;80:360-363.
139. Orth K, Russ D, Beck G, et al. Photochemotherapy of experimental colonie tumours with intra-tumorally applied methylene blue. Langenbecks Arch Surg. 1998;383:276-281.
140. Ziolkowski P, Symonowicz K, Osiecka BJ, et al. 5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice. Arch Immunol Ther Exp (Warsz). 1998;46:301-304.
141. Whitacre CM, Feyes DK, Satoh T, et al. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res. 2000;6:2021-2027.
142. Barr H, Tralau CJ, Boulos PB, et al. Selective necrosis in dimethylhydrazine-induced rat colon tumors using phthalocyanine photodynamic therapy. Gastroenterology. 1990;98:1532-1537.
143. Barr H, Chatlani P, Tralau CJ, et al. Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue. Gut. 1991 ;32:517-523.
144. Tralau CJ, Barr H, Sandeman DR, et al. Aluminum sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas. Photochem Photobiol. 1987;46:777-781.
145. Regula J, Ravi B, Bedwell J, et al. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer: prolonged animal survival. Br J Cancer. 1994;70:248-254.
146. Hamblin MR, Del Governatore M, Rizvi I, et al. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer. 2000;83:1544-1551.
147. Rovers JP, Schuitmaker JJ, Vahrmeijer AL, et al. Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases. Br J Cancer. 1998;77:2098-2103.
148. Fisher AM, Rucker N, Wong S, et al. Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines. J Photochem Photobiol B. 1998;42:104-107.
149. Nakamura T, Fukui H. Ishii Y, et al. Photodynamic therapy with polypectomy for rectal cancer. Gastrointest Endosc. 2003;57:266-269.
150. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med. 2001;344:1681-1687.
151. Scholefield JH. Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Tech Coloproctol. 2004; 8:200.
152. Rovers JP, Saarnak AE, Molina A, et al. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Br J Cancer. 1999;81:600-608.
153. Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc. 1999;49(suppl):20-23.
154. Greenwald BD. Photodynamic therapy for esophageal cancer: update. Chest Surg Clin North Am. 2000;10:625-637.
155. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997;114:824-829.
156. Nava HR. Photodynamic therapy in Barrett's high-grade dysplasia: are we ready to abandon esophagectomy for a more conservative therapy? J Surg Oncol. 1998;68:207-208.
157. Barbezat GO. New treatment for Barrett's oesophagus. Biomed Pharmacother. 2000;54:362-367.
158. Kubba AK, Krasner N. The emerging role of photodynamic therapy in the management of Barrett's oesophagus. Scand J Gastroenterol. 1998; 33:1121-1129.
159. van den Boogert J, van Hillegersberg R, Siersema PD, et al. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol. 1999;94:1153-1160.
160. Ell C. Clinical photodynamic therapy: where is it heading? [editorial] Endoscopy. 1998;30:408-411.
161. Yuasa N, Miyata K, Kobayashi Y, et al. Mucosal dysplasia in the bile duct after choledochoduodenostomy: a case report. Hepatogastroemerology. 2000;47:1238-1240.